Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
Global collaborators at the Heart of the Hutch
Advancing science to address the burden of cancer in low- and middle-income countries
In Uganda: Treating twin threats of HIV and cancer
Dr. Sue Desmond-Hellmann of the Bill & Melinda Gates Foundation visits Hutch researchers in Kampala
Interferon gamma brings the heat to cold tumors
From the Pollack Lab, Clinical Research Division
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Good News: Dr. Gary Gilliland speaks to members of Congress about federal research funding
Celebrating faculty and staff achievements
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Using a virus to teach the immune system to kill cancer
‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Q&A with the author of ‘The Radium Girls’: A new story chronicles century-old fight for workplace safety
Author Kate Moore in conversation with cancer researcher Dr. Anne McTiernan
Good News: First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy
Celebrating faculty and staff achievements
First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy
Some types of sarcomas elicit a greater immune response than others, which sheds light on how immunotherapy could be used for this connective-tissue cancer, according to a new study in Cancer.
Deploying an ancient defense to kill cancer
In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug
Childhood cancer survivor still inspires Fred Hutch researcher
A budding scientist finds his calling in the lab — years after a Hutch internship with the doctor who diagnosed his rare childhood kidney cancer
Chance of surviving childhood cancer has improved — but survivors’ overall health has not
In large study of childhood cancer survivors, self-reported health remained constant or declined for patients treated in recent decades
About half with cancer face a religious struggle; a patient, chaplain and grieving mom reveal how cancer reshaped their views
About half of those with cancer face a religious struggle; a patient, chaplain and grieving mom reveal how cancer reshaped their views
When cancer is a side effect of cancer
Childhood cancer survivors twice as likely to be diagnosed with a second cancer after 40, study finds
Good News at Fred Hutch
Hutch scientists, community advisors featured at International AIDS Society conference; Dr. Lee Cranmer to lead sarcoma program
It’s not cheating: Why oncologists want you to get a second opinion
Second (or third or fourth) opinions don’t always change cancer treatment, but they’re still important, experts say
Uganda program breaks ground for pioneering cancer center
First comprehensive cancer center collaboration by U.S. and sub-Saharan African cancer institutions will further specialized study, treatment of infection-related cancers